Form 8-K · Current report
Salesforce 8-K, filed Oct 20, 2026
- Filed
- CIK
- 0001108524
- Accession no.
- 0001193125-26-425881
Summary
Salesforce has entered a definitive agreement to acquire Braze for approximately $5.66 billion in enterprise value, with Braze Class A common stockholders receiving $47.50 in cash per share. The deal is expected to close in Salesforce's fiscal year 2028, subject to Braze shareholder approval and required regulatory approvals, and Salesforce said it does not anticipate a change to its FY27 guidance.
Key points
- Braze serves approximately 2,770 customers, including Canva, Dairy Queen, Equinox, Instacart, Urban Outfitters and Venmo.
- Salesforce said Braze's real-time engagement and AI decisioning capabilities are expected to complement Data 360, Customer 360, Agentforce and SIForce.
- J.P. Morgan Securities is exclusive financial advisor to Salesforce, with Wachtell, Lipton, Rosen & Katz and Covington & Burling as legal counsel.
- Qatalyst Partners is exclusive financial advisor to Braze, with Davis Polk & Wardwell as legal counsel.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 7.01 Regulation FD Disclosure. On October 20, 2026, Salesforce, Inc. (the “Company” or “Salesforce”) and Braze, Inc. (“Braze”) issued a joint press release announcing a definitive agreement pursuant to which the Company will acquire Braze on the terms and subject to the conditions set forth therein. The press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. Also on October 20, 2026, the Company published an investor webinar in connection with the transaction. A copy of the investor webinar is attached hereto as Exhibit 99.2 and is incorporated by reference herein. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.